Novel Targets and Biomarkers for Anti-atherosclerotic Therapy

被引：0
|
作者：
Bobryshev, Yuri V. [1 ,2 ]
机构：
[1] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia
[2] St Vincents Hosp, Sydney, NSW 2052, Australia
来源：
CURRENT PHARMACEUTICAL DESIGN | 2013年 / 19卷 / 33期
关键词：
atherosclerosis; atherogenesis; targets; biomarkers; anti-atherosclerotic therapy; T cells; macrophages; dendritic cells; immune-inflammatory cells; ATHEROSCLEROSIS; LDL;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：5837 / 5839
页数：3
相关论文
共 50 条
  • [31] Insulin Is an Anti-inflammatory and Anti-atherosclerotic Hormone
    Dandona, Paresh
    Aljada, Ahmad
    O'Donnell, Amy
    Dhindsa, Sandeep
    Garg, Rajesh
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2004, 2 (02) : 137 - +
  • [32] Effect of pharmacologic anti-atherosclerotic therapy on carotid intraplaque neovascularization: A systematic review
    Cui, Edward
    Kersche, Georgia
    Grubic, Nicholas
    Hetu, Marie-France
    Pang, Stephen C.
    Sillesen, Henrik
    Johri, Amer M.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (03) : 315 - 326
  • [33] Phytoestrogen-Rich Dietary Supplements in Anti-Atherosclerotic Therapy in Postmenopausal Women
    Sobenin, Igor A.
    Myasoedova, Veronica A.
    Orekhov, Alexander N.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (02) : 152 - 163
  • [34] EFFECT OF PHARMACOLOGIC ANTI-ATHEROSCLEROTIC THERAPY ON CAROTID INTRAPLAQUE NEOVASCULARIZATION: A SYSTEMATIC REVIEW
    Cui, Edward
    Kersche, Georgia
    Grubic, Nicholas
    Hetu, Marie-France
    Pang, Stephen
    Johri, Amer
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1460 - 1460
  • [35] Effect of Two Chronic Exercise Protocols on Pre-Atherosclerotic and Anti-Atherosclerotic Biomarkers Levels in Obese and Overweight Children
    Paahoo, Alireza
    Tadibi, Vahid
    Behpoor, Nasser
    [J]. IRANIAN JOURNAL OF PEDIATRICS, 2020, 30 (02) : 1 - 7
  • [36] Inhibition of LDL-associated phospholipase A(2): A novel anti-atherosclerotic approach
    Macphee, CH
    Boyd, HF
    Dhanak, D
    Ife, RJ
    Leach, CA
    Milliner, KJ
    Moores, KE
    Suckling, KE
    Tew, DG
    Hickey, DMB
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 225 - 225
  • [37] Animal models to evaluate anti-atherosclerotic drugs
    Priyadharsini, Raman P.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 (04) : 329 - 340
  • [38] Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril
    Fonseca, FAH
    Ihara, SSM
    Izar, MCO
    Silva, EP
    Kasinski, N
    Lopes, IEL
    Pinto, LESA
    Paiva, TB
    Tufik, S
    de Paola, AAV
    Carvalho, ACC
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (10) : 779 - 785
  • [39] Repurposing nitazoxanide as a novel anti-atherosclerotic drug based on mitochondrial uncoupling mechanisms
    Ma, Ming-Hui
    Li, Feng-Feng
    Li, Wen-Feng
    Zhao, Hui
    Jiang, Man
    Yu, Yuan-Yuan
    Dong, Yan-Chao
    Zhang, Yi-Xin
    Li, Ping
    Bu, Wen-Jie
    Sun, Zhi-Jie
    Dong, De-Li
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (01) : 62 - 79
  • [40] Anti-atherosclerotic effects of the hexapeptide angiotensin IV
    Vinh, Antony
    Widdop, Robert
    Gaspari, Tracey
    [J]. FASEB JOURNAL, 2008, 22
12345